Acute data collection that includes both direct and indirect comparisons of the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ in standard pulmonary vein isolation (PVI) confirmation workflows suggests that the device can identify gaps that may be missed by other technologies.
In a direct comparison, 18 patients received cryoablation with isolation confirmed by the Achieve‡ Mapping Catheter. Isolation was then checked again with the Advisor HD Grid Mapping Catheter, SE, revealing:
In a direct comparison, 22 patients received ablation with isolation confirmed by pacing the ablation line. Isolation was then checked again with the Advisor HD Grid Mapping Catheter, SE, revealing:
Close the Gap: Clinical Evidence
This document references three clinical studies for Advisor HD Grid Mapping Catheter, Sensor Enabled, sharing truncated links to the studies.
MAT-2007563 v1.0
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Precautions
Please be sure to read it.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.
Are you a healthcare professional?
Test
